how to get glp 1 if not obese GLP-1 Agonist: The Good, the Bad and the Ugly GLP-1 medications are now available

Given that obesity is a chronic and relapsing disease, it is important to understand the effectiveness of different strategies to maintain WL: TRIUMPH-6 (NCT06859268) will assess changes in bodyweight at 116 weeks in individuals with obesity who have completed 80 weeks of retatrutide, comparing continued treatment at high or low doses of retatrutide versus switching to placebo for the last 36 weeks

Can Peptides be Used with GLP-1 Medications

Our team put this together to quickly summarize the key distinctions for researchers trying to decide which compound is appropriate for their work

Setting realistic weight management goals can be beneficial for long-term success